Terms: = Uterine cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1
12 results:
1. [Treatment and prognosis analysis of 488 patients with FIGO 2018 stage Ⅲc squamous cervical cancer].
Feng T; Shou HF; Yuan SH; Tang HR; Lyu XJ; Yin ZM; Lou HM; Ni J
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):359-367. PubMed ID: 37217343
[No Abstract] [Full Text] [Related]
2. Claudin‑9 is a novel prognostic biomarker for endometrial cancer.
Endo Y; Sugimoto K; Kobayashi M; Kobayashi Y; Kojima M; Furukawa S; Soeda S; Watanabe T; Higashi AY; Higashi T; Hashimoto Y; Fujimori K; Chiba H
Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36129146
[TBL] [Abstract] [Full Text] [Related]
3. Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.
Martinez A; Chantalat E; Angeles MA; Ferron G; Ducassou A; Daix M; Attal J; Bétrian S; Lusque A; Gabiache E
BMC Cancer; 2022 Jul; 22(1):810. PubMed ID: 35870900
[TBL] [Abstract] [Full Text] [Related]
4. Promoters of and barriers to cervical cancer screening in a rural setting in Tanzania.
Perng P; Perng W; Ngoma T; Kahesa C; Mwaiselage J; Merajver SD; Soliman AS
Int J Gynaecol Obstet; 2013 Dec; 123(3):221-5. PubMed ID: 24095307
[TBL] [Abstract] [Full Text] [Related]
5. Tailoring adjuvant radiotherapy for stage IB-IIA node negative cervical carcinoma after radical hysterectomy and pelvic lymph node dissection using the GOG score.
Yeo RM; Chia YN; Namuduri RP; Yap SP; Soong YL; Yam PK; Lim TY; Khoo-Tan HS
Gynecol Oncol; 2011 Nov; 123(2):225-9. PubMed ID: 21782226
[TBL] [Abstract] [Full Text] [Related]
6. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract] [Full Text] [Related]
7. A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.
Madauss KP; Grygielko ET; Deng SJ; Sulpizio AC; Stanley TB; Wu C; Short SA; Thompson SK; Stewart EL; Laping NJ; Williams SP; Bray JD
Mol Endocrinol; 2007 May; 21(5):1066-81. PubMed ID: 17356170
[TBL] [Abstract] [Full Text] [Related]
8. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
[TBL] [Abstract] [Full Text] [Related]
9. Expression of estrogen receptor coregulators in normal and malignant human endometrium.
Kershah SM; Desouki MM; Koterba KL; Rowan BG
Gynecol Oncol; 2004 Jan; 92(1):304-13. PubMed ID: 14751175
[TBL] [Abstract] [Full Text] [Related]
10. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I
Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091
[TBL] [Abstract] [Full Text] [Related]
11. Estrogen receptor cofactors expression in breast and endometrial human cancer cells.
Thenot S; Charpin M; Bonnet S; Cavailles V
Mol Cell Endocrinol; 1999 Oct; 156(1-2):85-93. PubMed ID: 10612426
[TBL] [Abstract] [Full Text] [Related]
12. Prevalence and standardized incidence rates of preclinical cervical pathology among 1,061 women sterilized with transcervical quinacrine hydrochloride pellets.
Dabancens A; Sokal DC; Pruyas M; Rivera M; Zipper J
Fertil Steril; 1995 Aug; 64(2):444-6. PubMed ID: 7615128
[TBL] [Abstract] [Full Text] [Related]